Previous 10 | Next 10 |
Summary ResMed continues to be a leading company in the industry, with multiple growth drivers ahead of its 2025 goals. But the outlook for ResMed doesn't look good, with YoY figures slowing and dividend payments possibly being interrupted. This has called its high valuation multipl...
Summary Intuitive Surgical, Inc. is no doubt a nearly perfect company, although the investment is currently worrisome. With continued headwinds and a lofty valuation, a lot rides on what Intuitive Surgical will do with their $4 billion in cash. This article will summarize recent Int...
Summary Zimmer Biomet has been struggling, or better said, stagnating for years. Lack of progress has pretty much been the case since the tie-up between Zimmer and Biomet. Valuations remain demanding, or at least full, given the past performance. It has been all the way ba...
Summary Intuitive Surgical has enjoyed years of strong growth but there is still more room for further expansion for all major revenue streams. Ion Endoluminal is expected to remain a relatively small revenue stream. Competition is increasing which may pressurize margins and market ...
Zimmer Biomet Announces Webcast and Conference Call of Fourth Quarter 2022 Financial Results PR Newswire WARSAW, Ind. , Jan. 6, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its fourth quarter earnings conference call will ...
Zimmer Biomet Holdings ( NYSE: ZBH ) announced an agreement on Thursday to buy Embody, Inc., a privately held medical device company focused on soft tissue healing. Per the terms, Zimmer ( ZBH ) will acquire Embody for $155M at the closing and up to $120M in additional payments, s...
Zimmer Biomet to Acquire Embody, Inc. PR Newswire Deal Strengthens Zimmer Biomet's Growing Sports Medicine Portfolio and Supports Continued Company Transformation WARSAW, Ind. , Jan. 5, 2023 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZB...
Zimmer Biomet Announces Quarterly Dividend for Fourth Quarter of 2022 PR Newswire WARSAW, Ind. , Dec. 15, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has ap...
Zimmer Biomet to Present at Goldman Sachs CEOs Unscripted Conference and 41st Annual J.P. Morgan Healthcare Conference PR Newswire WARSAW, Ind. , Dec. 14, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, t...
Summary CONMED Corporation had a reasonable growth quarter with upsides in key markets. Orthopedics is certainly an exciting growth area and offers leverage with each additional gain in market share. We'd like more time to assess any changes before pulling the trigger on CONMED Corp...
News, Short Squeeze, Breakout and More Instantly...
Zimmer Biomet Holdings Inc. Company Name:
ZBH Stock Symbol:
NYSE Market:
Zimmer Biomet Holdings Inc. Website:
2024-07-15 16:36:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results PR Newswire WARSAW, Ind. , July 8, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will ...
Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors PR Newswire WARSAW, Ind. , June 20, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Devdatt "Dev" Kurdika...